(Date:12/11/2009)... 11 Algeta ASA (OSE: ALGETA), ... clinical center in the,US, the Tulane Cancer ... the phase III clinical study of Alpharadin ... prostate cancer,(CRPC) that has metastasized to the ... ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) study ...
(Date:12/10/2009)... 10 Dendreon Corporation (Nasdaq: DNDN ) ... offering of 15,000,000 shares of its common stock at ... Dendreon also granted to the underwriters a 30-day ... of common stock to cover overallotments, if any. ... 2009, subject to customary closing conditions. ,, J. P. ...
(Date:12/10/2009)... Newly published research, by investigators, ... Institute (NESCI) in the journal STEM CELLS ... patients with "Limbal Stem Cell Deficiency" (LSCD) ... the need of suppressing their immunity. ... is a painful, blinding disease that requires ...
(Date:12/10/2009)... /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin Board: ... developer and,producer of prescription drugs and licensed ... Republic of China ("PRC"), today reported that,effective ... operating entity of Lotus,appointed Mr. Jinzhong HAN ... Drug division ("OTC Division"). , ...
Breaking Biology Technology:Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3... Novavax, Inc.,(Nasdaq: NVAX ) and the ... from a preclinical study of a Respiratory Syncytial ... worldwide rights from the, University of Massachusetts Medical ... commercialization of Paramyxovirus vaccines incorporating,certain Virus-Like-Particles ("VLPs"). ...
... NOVATO, Calif., Dec. 9 BioMarin Pharmaceutical,Inc. ... that its partner Merck Serono, a division,of ... approval for,Kuvan(R) (sapropterin dihydrochloride) for the treatment ... deficient patients,from the European Commission. Merck ...
... favorable results from a Phase 1 vehicle-controlled study of ... during urological surgery. , , ... patients undergoing endoscopic removal of urinary stones, and was ... the drug product. The pharmacokinetic data from this study ...
Other Biology Technology:NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate 2NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate 3NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate 4Kuvan Receives Marketing Approval in the European Union 2Kuvan Receives Marketing Approval in the European Union 3Kuvan Receives Marketing Approval in the European Union 4Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery 2... (Klenow) Fragment, Exonuclease Minus, is a DNA-dependent ... and the 3´→5´ exonuclease activities present in ... It is used for random primer labeling ... Klenow Fragment, Exonuclease Minus, will leave a ...
Goat polyclonal to Duffy / FY / DARC...
... The Centra-CL5R multi-purpose centrifuge offers both ... large assortment of rotor options, making ... laboratory applications., Maximum Versatility , ... xg) angle rotors or high-volume (4 x ...
... The H2OBIT is a fully licensed, high throughput, ... processing of up to 24 microplates. This equates ... plates. A robotic arm rapidly transfers ... resulting in temperature ramping times that are considerably ...
Biology Products:Biology NavigationMedical Navigation